Health tech evolves: Evolent Health files for a $100 million IPO

Evolent Health, which offers health care providers a software platform that manages a value-based care model, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering.

The Arlington, VA-based company, which was founded in 2011 and booked $101 million in sales for the fiscal year ended December 31, 2014, plans to list on the NYSE under the symbol EVH. Evolent Health initially filed confidentially on 12/24/2014. J.P. Morgan and Goldman Sachs are the joint bookrunners on the deal. No pricing terms were disclosed.

The article Health tech evolves: Evolent Health files for a $100 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.